Chien-an Liu

No. 201, Sec. 2, Shipai Road
Taipei, TNQ 11217, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

MRI features outperform histologic grade for outcome prediction in translocation-driven enriched soft-tissue sarcoma.

MRI features outperform histologic grade for outcome prediction in translocation-driven enriched soft-tissue sarcoma.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: May 07, 2026

Opportunistic L1 Attenuation on 100-kVp LDCT Predicts Ten-Year Fragility Fracture Risk in Postmenopausal Women in a Self-Paid Health Check-up Cohort.

Opportunistic L1 Attenuation on 100-kVp LDCT Predicts Ten-Year Fragility Fracture Risk in Postmenopausal Women in a Self-Paid Health Check-up Cohort.

Journal: Academic radiology

Published: April 10, 2026

Re-evaluating the anatomy of iatrogenic chylothorax - lymphangiography imaging of the transverse branch of the thoracic duct.

Re-evaluating the anatomy of iatrogenic chylothorax - lymphangiography imaging of the transverse branch of the thoracic duct.

Journal: Updates in surgery

Published: February 12, 2026

Interactive Roles of Metabolic Dysfunction-Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection.

Interactive Roles of Metabolic Dysfunction-Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection.

Journal: The Kaohsiung journal of medical sciences

Published: January 24, 2026

Lenvatinib Added to Nivolumab and Ipilimumab Improves Tumor Control and Progression-Free Survival in Unresectable Hepatocellular Carcinoma.

Lenvatinib Added to Nivolumab and Ipilimumab Improves Tumor Control and Progression-Free Survival in Unresectable Hepatocellular Carcinoma.

Journal: Liver cancer

Published: December 27, 2025

Patterns and Prognostic Stratification of Recurrence after Thermal Ablation in Patients with Hepatocellular Carcinoma.

Patterns and Prognostic Stratification of Recurrence after Thermal Ablation in Patients with Hepatocellular Carcinoma.

Journal: Liver cancer

Published: August 13, 2025

Taiwan liver cancer association management consensus guidelines for intermediate-stage hepatocellular carcinoma.

Taiwan liver cancer association management consensus guidelines for intermediate-stage hepatocellular carcinoma.

Journal: Clinical and molecular hepatology

Published: July 03, 2025

Risk factors associated with complications and local tumour progression in image-guided triple-freezing cryoablation for lung tumour: a longitudinal study.

Risk factors associated with complications and local tumour progression in image-guided triple-freezing cryoablation for lung tumour: a longitudinal study.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: May 05, 2025

Ice ball size and temperature change during cryoablation in a lard and an ethiodized-oil tissue phantom.

Ice ball size and temperature change during cryoablation in a lard and an ethiodized-oil tissue phantom.

Journal: Cryobiology

Published: January 24, 2025

Coil or plug-assisted retrograde transvenous obliteration (CARTO/PARTO) for treating portal hypertensive variceal bleeding: A multicenter, real-world 10-year retrospective study.

Coil or plug-assisted retrograde transvenous obliteration (CARTO/PARTO) for treating portal hypertensive variceal bleeding: A multicenter, real-world 10-year retrospective study.

Journal: Hepatology (Baltimore, Md.)

Published: December 18, 2024

Assessment of Y-90 Radioembolization Treatment Response for Hepatocellular Carcinoma Cases Using MRI Radiomics.

Assessment of Y-90 Radioembolization Treatment Response for Hepatocellular Carcinoma Cases Using MRI Radiomics.

Journal: Molecular imaging and radionuclide therapy

Published: October 07, 2024

PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma.

PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma.

Journal: BMC cancer

Published: September 30, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026